ES8707507A1 - Un procedimiento para preparar derivados de pirazinona - Google Patents

Un procedimiento para preparar derivados de pirazinona

Info

Publication number
ES8707507A1
ES8707507A1 ES530024A ES530024A ES8707507A1 ES 8707507 A1 ES8707507 A1 ES 8707507A1 ES 530024 A ES530024 A ES 530024A ES 530024 A ES530024 A ES 530024A ES 8707507 A1 ES8707507 A1 ES 8707507A1
Authority
ES
Spain
Prior art keywords
group
hydrogen
formula
alcohyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530024A
Other languages
English (en)
Other versions
ES530024A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300476A external-priority patent/GB8300476D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8707507A1 publication Critical patent/ES8707507A1/es
Publication of ES530024A0 publication Critical patent/ES530024A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

UN PROCEDIMIENTO PARA PREPARAR DERIVADOS DE PIRAZINONA. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) EN DONDE R2 Y R3 SON INDEPENDIENTEMENTE HIDROGENO O ALCOHILO C1-4 Y R12 ES NITRO O UN GRUPO R10NH- SIENDO R10 UN GRUPO PROTECTOR, CON UN COMPUESTO DE FORMULA (III), DONDE R1 ES HIDROGENO O ALCOHILO C1-4; DESPUES DE ELLO, SI ES NECESARIO, SE REDUCEN LOS GRUPOS NITRO Y SE ELIMINAN LOS GRUPOS PROTECTORES. DEPENDIENDO DE LAS CONDICIONES DE REACCION SE PUEDEN OBTENER UNA VARIEDAD DE COMPUESTOS DE FORMULA GENERAL (I), DONDE R1, R2 Y R3 TIENEN LOS MISMOS SIGNIFICADOS ANTERIORES Y R4 ES HIDROGENO, UN GRUPO ALCOXI C1-6 CARBONILO, ALCOXI C1-4 O CARBOXI, O UN GRUPO -CO-(NR5)N-R6. SON AGENTES CARDIOTONICOS Y VASODILATADORES.
ES530024A 1982-06-05 1984-02-24 Un procedimiento para preparar derivados de pirazinona Granted ES530024A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8216437 1982-06-05
GB838300476A GB8300476D0 (en) 1983-01-08 1983-01-08 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
ES8707507A1 true ES8707507A1 (es) 1985-12-01
ES530024A0 ES530024A0 (es) 1985-12-01

Family

ID=26283037

Family Applications (2)

Application Number Title Priority Date Filing Date
ES522962A Expired ES8500244A1 (es) 1982-06-05 1983-06-03 "un procedimiento para preparar derivados de pirazinona"
ES530024A Granted ES530024A0 (es) 1982-06-05 1984-02-24 Un procedimiento para preparar derivados de pirazinona

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES522962A Expired ES8500244A1 (es) 1982-06-05 1983-06-03 "un procedimiento para preparar derivados de pirazinona"

Country Status (15)

Country Link
US (2) US4514568A (es)
EP (1) EP0096517A3 (es)
KR (1) KR840005111A (es)
AU (1) AU1527583A (es)
DD (1) DD209818A5 (es)
DK (1) DK247783A (es)
ES (2) ES8500244A1 (es)
FI (1) FI831998L (es)
GR (1) GR79299B (es)
JO (1) JO1255B1 (es)
NO (1) NO832016L (es)
PL (1) PL242354A1 (es)
PT (1) PT76791B (es)
RO (1) RO86851B (es)
ZW (1) ZW12783A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4595766A (en) * 1984-10-26 1986-06-17 Ciba-Geigy Corporation Process for the preparation of an indoline carboxylic acid
US4697016A (en) * 1984-10-26 1987-09-29 Ciba-Geigy Corporation Intermediates for the preparation of a carboxylic acid
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
JP2013502429A (ja) * 2009-08-19 2013-01-24 アムビト ビオスシエンセス コルポラチオン ビアリール化合物及びその使用方法
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
CN104718201A (zh) * 2012-06-12 2015-06-17 艾伯维公司 吡啶酮和哒嗪酮衍生物
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745161A (en) * 1970-04-20 1973-07-10 Merck & Co Inc Phenyl-hydroxy-pyrazine carboxylic acids and derivatives

Also Published As

Publication number Publication date
DK247783A (da) 1983-12-06
ES522962A0 (es) 1984-10-01
ZW12783A1 (en) 1983-08-24
ES8500244A1 (es) 1984-10-01
JO1255B1 (en) 1985-04-20
KR840005111A (ko) 1984-11-03
EP0096517A3 (en) 1985-04-03
DD209818A5 (de) 1984-05-23
US4514568A (en) 1985-04-30
PT76791A (en) 1983-07-01
US4556711A (en) 1985-12-03
AU1527583A (en) 1983-12-08
ES530024A0 (es) 1985-12-01
DK247783D0 (da) 1983-06-01
PT76791B (en) 1986-01-24
NO832016L (no) 1983-12-06
RO86851A (ro) 1985-05-20
FI831998A0 (fi) 1983-06-03
EP0096517A2 (en) 1983-12-21
FI831998L (fi) 1983-12-06
GR79299B (es) 1984-10-22
PL242354A1 (en) 1984-12-17
RO86851B (ro) 1985-05-31

Similar Documents

Publication Publication Date Title
ES8707507A1 (es) Un procedimiento para preparar derivados de pirazinona
GB1374435A (en) N-substituted tetrahydrophthalimides
ES8607982A1 (es) Un procedimiento para preparar un derivado de uridina
ES8301917A1 (es) Procedimiento para preparar intermedios de ftalimidinas y ftalacinonas
ES458721A1 (es) Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos.
ATE15668T1 (de) Verfahren zur herstellung von thiazolidinderivaten.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
ES398427A1 (es) Un procedimiento para preparar 3-amido-1,2,4-triazoles.
ES274330A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
ES8602786A1 (es) Derivados de pirimidoisoquinolina
ES8302703A1 (es) "un procedimiento para la preparacion de fenil-quinolicidinas".
ES421076A1 (es) Procedimiento para la obtencion de 1-ariloxi-3-aralquilami-no-2-propanoles.
ES469164A1 (es) Procedimiento para la preparacion de 2-bencil-perhidroazepi-nas
ES8302005A1 (es) Procedimiento para preparar compuestos cefalosporanicos
ES478144A1 (es) Un procedimiento de produccion de compuestos heterociclicos nitrogenados.
ES8304951A1 (es) Un procedimiento para la preparacion de un compuesto de alofanoilpiperazina.
ES419548A1 (es) Procedimiento para la preparacion de indazoles sustituidos.
ES483796A1 (es) Un procedimiento para la preparacion de derivados del acido-penam-3-carboxilico.
ES392665A1 (es) Un procedimiento para preparar derivados de benzodiazepina-1-sustituidos y sales de los mismos.
ES8305732A1 (es) Procedimiento para preparar derivados de imidazol.
ES8201970A1 (es) Procedimiento de obtencion de derivados de 3-aril-5-metilpi-rroles a partir del nitroestirenos y compuestos dicarbonili-cos
ES454090A1 (es) Un metodo para preparar compuestos heterociclicos.
ES469913A1 (es) Un procedimiento para la preparacion de nuevos derivados de 6,11-dihidrobenzo-(b.e.)-tiepin-11-ona.
ES292201A1 (es) Método para la preparación de nuevos compuestos heterocíclicos de nitrofurilvinilo
ES8201975A1 (es) Procedimiento para preparar nuevos compuestos de quinolona